Papillary serous carcinoma of the ovary following prolonged tamoxifen treatment

Eur J Gynaecol Oncol. 1999;20(3):237-9.

Abstract

We present a patient with breast cancer who developed papillary serous adenocarcinoma of the ovary after 13 years of tamoxifen use. The possible association is explored and the literature is reviewed.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Aged
  • Breast Neoplasms / drug therapy*
  • Cystadenocarcinoma, Papillary / chemically induced*
  • Estrogen Antagonists / adverse effects*
  • Female
  • Humans
  • Ovarian Neoplasms / chemically induced*
  • Tamoxifen / adverse effects*

Substances

  • Estrogen Antagonists
  • Tamoxifen